| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.12B | 38.80B | 34.22B | 37.06B | 32.35B | 29.16B |
| Gross Profit | 8.96B | 8.59B | 7.87B | 9.03B | 8.03B | 6.37B |
| EBITDA | 4.82B | 4.31B | 21.28B | 4.29B | 3.74B | 3.03B |
| Net Income | 2.82B | 2.47B | 14.15B | 1.84B | 1.78B | 1.55B |
Balance Sheet | ||||||
| Total Assets | 44.58B | 45.32B | 44.80B | 30.39B | 28.30B | 22.79B |
| Cash, Cash Equivalents and Short-Term Investments | 9.84B | 9.91B | 9.91B | 11.33B | 9.04B | 8.26B |
| Total Debt | 2.62B | 2.73B | 2.84B | 3.38B | 4.13B | 2.08B |
| Total Liabilities | 15.33B | 15.71B | 15.41B | 14.20B | 14.25B | 11.74B |
| Stockholders Equity | 28.78B | 29.14B | 28.96B | 14.96B | 13.22B | 10.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.70B | 2.74B | 3.09B | -121.11M | 2.90B |
| Operating Cash Flow | 0.00 | 2.75B | 3.15B | 3.31B | 682.47M | 3.08B |
| Investing Cash Flow | 0.00 | 552.24M | -2.07B | -1.32B | -844.81M | -528.91M |
| Financing Cash Flow | 0.00 | -3.30B | -1.40B | -414.84M | 535.09M | -719.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥32.96B | 11.66 | ― | 2.97% | 16.59% | 40.56% | |
74 Outperform | ¥267.56B | 28.54 | ― | 0.22% | 25.00% | 62.07% | |
73 Outperform | ¥186.59B | 9.34 | ― | 2.55% | 10.98% | 8.65% | |
73 Outperform | ¥46.22B | 18.47 | 17.50% | 2.88% | 5.62% | 3.81% | |
71 Outperform | ¥22.86B | 11.39 | ― | 1.70% | 22.25% | 31.88% | |
65 Neutral | ¥30.85B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |